Shield Therapeutics revenue jumps on rising Accrufer prescriptions
(Alliance News) - Shield Therapeutics PLC on Wednesday said it is on track to turn free cash flow positive by the end of the year, as the pharmaceutical company reported a sharp rise in second quarter revenue. Read More